// App-Quantinova.ai

2771 : Three-Dimensional Nuclear Telomeric Organization (3D) of Chronic Myeloid Leukemia Patients Predicts Accelerated Phase and Blast Crisis.

Researchers

Presenter

  • Ferdinando de Paula Silva

Principal Investigators

  • Ana Paula N Rodrigues Alves

  • Belinda Pinto Simoes

  • Roberto P. Falcao

  • Sabine Mai

Medical Centers

  • Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Canada

  • Internal Medicine - Hematology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, FMRP/USP, Ribeirao Preto, Brazil

  • Internal Medicine - Hematology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, FMRP/USP, Ribeirao Preto, Brazil

  • Internal Medicine - Hematology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, FMRP/USP, Ribeirao Preto, Brazil

  • Internal Medicine - Hematology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, FMRP/USP, Ribeirao Preto, Brazil

Locations

  • Brazil

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved